Increasing prevalence of pigmented lesions is driving the demand for its treatment globally. Pigmented lesions is one of the most common skin condition found among the geriatric population. It mostly appears on the face, however marks can emerge on other body parts as well. Aging and extreme sun exposure are considered as two of the leading causes of pigmented lesions. Other causes of the condition include exogenous and endogenous both malignant and benign aetiologies.
Today, a spectrum of medications, therapies and laser treatment is available that can effectively treat and remove pigmented lesions marks. Pharmaceutical companies are introducing non-invasive med-aesthetic systems that can effectively reduce the impact of the condition. These novel medications are reliable, safe and comfortable. Moreover, many of these latest therapies are capable of clearing various types of skin effects of vascular and pigmented lesions without any side effects.
There are various types of pigmented lesion conditions, which include erythema, broken capillaries, poikilormera, solar lentigo, melisma, telangiectasia, rosacea, dyschromia, mottled and pigmentation. These condition can arise from an array of environmental and natural causes such as aging process, photodamage, and genetic makeup. In some cases, the condition may also be caused from side effects of certain medical procedures. Marks that occur from pigmented lesion can emerge in forms of pigment-related birthmarks, freckles, pigmented nevi, age spots, actinic keratosis and hyperpigmentation.
Intake of toxic substances, excessive use of synthetic cosmetics and smoking can also lead to pigmented lesion. Future Market Insights (FMI)’s new report reveals that the global pigmented lesion treatment market is set to surge at a CAGR of 6.5% during the forecast period (2017-2022)
North America at the Forefront of Global Pigmented Lesion Treatment Market
North America is expected to remain the largest market for pigmented lesion treatment market during the forecast period. In terms of revenue, the region is expected to remain highly attractive in 2017 and beyond. This is primarily owing to high consumer awareness regarding availability of various pigmented lesion treatment devices. Between 2017 and 2022, North America pigmented lesions treatment market is projected to register a CAGR of 7%.
This growth is likely to be characterised by factors such as widespread availability of advanced skin treatment techniques and presence of leading market players in the region. Moreover, elderly consumers in the region are increasingly opting for skincare therapies that can make them look younger as well as reduce various skin diseases including pigmented lesion.
IPL Devices a Leading Product Type Segment
On the basis of products, the IPL devices segment is expected to retain its top position over the assessment period. The segment currently represents for nearly 50% market share in terms of revenue and is estimated to surpass a valuation of US$ 190 Mn by 2022, reflecting a sound CAGR. Meanwhile, the energy based devices segment is estimated to account for the second largest revenues share of the market over 2022. This segment is likely to create an absolute $ opportunity of US$ 19.7 Mn between 2017 and 2022.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Dermatology Clinics will remain the Leading End User of Pigmented Lesion Treatment Devices Over 2022
On the basis of end user, the dermatology clinic segment is expected to remain highly attractive throughout the forecast period. The segment currently accounts for an overwhelming percent of market share in terms of revenues and is expected to exhibit 5.8% CAGR from 2017 to 2022.
Leading market players profiled in FMI’s report include Alma Lasers, Ltd., Fotona d.d., Sciton, Inc., EL.En. S.p.A., Lynton Lasers Ltd, Solta Medical Inc., Lumenis Ltd., Cynosure, Inc., Strata Skin Sciences, Inc., Syneron Medical Ltd., Lutronic Corporation, and Cutera Inc.
Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Future Market Insights
The report on the global market for pigmented lesion treatment cover an elaborated segmentation with the help of which various implications of the sub segment breakdown, market’s growth, regional scenario etc., can be identified.
- Energy Based Devices
- RF Devices
- Ultrasound Devices
- IPL Devices
- Dermatology Clinics
- Beauty Clinics